ROSA®
-
Recon
Zimmer Biomet Announces Successful Completion of World’s First Robotic-Assisted Shoulder Replacement Surgery with ROSA® Shoulder System
WARSAW, Ind., April 25, 2024 – Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today…
Read More » -
Regulatory
Zimmer Biomet Receives FDA Clearance for ROSA® Shoulder System – the World’s First Robotic Assistant for Shoulder Replacement Surgery
The ROSA® Shoulder System Becomes the First-to-Market Robotic Surgical Assistant for Shoulder Arthroplasty and the Fourth ROSA Robotics Application in Five…
Read More » -
Recon
Zimmer Biomet Receives FDA Clearance for ROSA® Hip System for Robotically-Assisted Direct Anterior Total Hip Arthroplasty
ROSA® Hip and ONE Planner™ Hip Further Strengthens Zimmer Biomet’s Comprehensive ROSA® Robotics Portfolio; Enhances ZBEdge and Complements Already Available…
Read More » -
Recon
Zimmer Biomet Receives FDA Clearance for ROSA® Partial Knee System for Robotically-Assisted Partial Knee Arthroplasty
WARSAW, Ind., April 20, 2021 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today…
Read More » -
Recon
Zimmer Biomet Receives FDA Clearance for ROSA® Knee System for Robotically-Assisted Surgeries
WARSAW, Ind., Jan. 25, 2019 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today…
Read More »